Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.
2.

Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.

Mannix LK, Savani N, Landy S, Valade D, Shackelford S, Ames MH, Jones MW.

Headache. 2007 Jul-Aug;47(7):1037-49.

PMID:
17635595
3.

Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.

Newman L, Mannix LK, Landy S, Silberstein S, Lipton RB, Putnam DG, Watson C, Jöbsis M, Batenhorst A, O'Quinn S.

Headache. 2001 Mar;41(3):248-56.

PMID:
11264684
4.

Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.

Ashcroft DM, Millson D.

Pharmacoepidemiol Drug Saf. 2004 Feb;13(2):73-82.

PMID:
14998068
6.

Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan.

Stark S, Spierings EL, McNeal S, Putnam GP, Bolden-Watson CP, O'Quinn S.

Headache. 2000 Jul-Aug;40(7):513-20.

PMID:
10940089
7.

Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.

Lipton RB, Pascual J, Goadsby PJ, Massiou H, McCarroll KA, Vandormael K, Jiang K, Lines CR.

Headache. 2001 Sep;41(8):754-63.

PMID:
11576198
9.

Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.

Göbel H, Winter P, Boswell D, Crisp A, Becker W, Hauge T, Mihout B, Niewold J, Tørring J.

Clin Ther. 2000 Aug;22(8):981-9.

PMID:
10972634
10.

Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group.

Havanka H, Dahlöf C, Pop PH, Diener HC, Winter P, Whitehouse H, Hassani H.

Clin Ther. 2000 Aug;22(8):970-80.

PMID:
10972633
11.

Rizatriptan: an update of its use in the management of migraine.

Wellington K, Plosker GL.

Drugs. 2002;62(10):1539-74. Review.

PMID:
12093318
12.

Spotlight on rizatriptan in migraine.

Wellington K, Jarvis B.

CNS Drugs. 2002;16(10):715-20. Review.

PMID:
12269863
13.
14.

Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.

Bomhof M, Paz J, Legg N, Allen C, Vandormael K, Patel K.

Eur Neurol. 1999;42(3):173-9.

PMID:
10529545
15.

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.

Tfelt-Hansen P, De Vries P, Saxena PR.

Drugs. 2000 Dec;60(6):1259-87. Review.

PMID:
11152011
16.

Naratriptan: an alternative for migraine.

Dulli DA.

Ann Pharmacother. 1999 Jun;33(6):704-11. Review.

PMID:
10410185
17.

Frovatriptan: a review of its use in the acute treatment of migraine.

Sanford M.

CNS Drugs. 2012 Sep 1;26(9):791-811. doi: 10.2165/11209380-000000000-00000. Review.

PMID:
22900951
18.

Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.

McCormack PL, Foster RH.

Pharmacoeconomics. 2005;23(12):1283-98. Review.

PMID:
16336021
19.

Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.

Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.

Headache. 2009 Jul;49(7):971-82. doi: 10.1111/j.1526-4610.2009.01458.x. Epub 2009 May 27.

PMID:
19486178
20.

Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials.

Bussone G, D'Amico D, McCarroll KA, Gerth W, Lines CR.

Eur Neurol. 2002;48(3):172-7.

PMID:
12373035
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk